A Healthesystems publication

Fall 2014

Breaking the Opioid Cycle: Prevention Strategies

Prevention — the most proactive intervention for opioid abuse — often occurs at the point of care. However, the responsibility does not fall solely on the prescriber at this juncture. Each stakeholder has a role to play when it comes to ensuring appropriate prescribing and dispensing of opioid therapy.

Pain is the unfortunate result of many workplace injuries. And as many payers are aware, pain is often managed through the prescribing of opioids. Too often, however, an opioid prescription that was originally intended to manage acute short-term pain following a severe injury or surgery leads to long-term use, a practice not recommended by medical guidelines. Chronic use may lead to undesirable consequences such as misuse, abuse, dependence, and addiction. The price of opioid abuse is high, from any perspective.

To continue reading you must be logged in.

Please register for free or login to unlock the rest of this article.

RATE THIS ARTICLE

SOURCES

1 - Centers for Disease Control and Prevention. Wide-ranging OnLine Data for Epidemiologic Research (WONDER) [online]. (2014) Available from URL: http://wonder.cdc.gov/mortsql.html .
2 -U.S. Department of Justice. Drug Enforcement Administration. Lists of: Scheduling Actions Controlled Substances Regulated Chemicals. September 2014. Available at: http://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf . Accessed 10/22/14.
3 -Louisiana Board of Pharmacy Bulletin No. 14-03. July 15, 2014. Available at: http://www.pharmacy.la.gov/assets/docs/Bulletins/Bulletin_14-03.pdf . Accessed 10/22/14.
4 -Office of the Federal Register [US]. Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II. A Rule by the Drug Enforcement Administration on 08/22/2014. Available at: https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule . Accessed10/21/14.
5 -PDMP: The Game Changer? Healthesystems. RxInformer Spring 2013. Page 24. Available at: www.healthesystems.com/rxinformer . Accessed 10/22/14
6 -Walstin, Brian. State Takes Next Step in Monitoring Prescription Drug Abuse. New Hampshire Public Radio. Available at: http://nhpr.org/post/state-takes-next-step-monitoring-prescription-drug-abuse . Accessed 10/22/14.
7 -Schwarz, Alan. Missouri Alone in Resisting Prescription Drug Database. NY Times. July 20, 2014. Available at: http://www.nytimes.com/2014/07/21/us/missouri-alone-in-resisting-prescription-drug-database.html?_r=0 . Accessed 10/22/14.
8 -Oregon Health Authority. Prescription drug dispensing in Oregon. October 2011-March 2012. Available at: http://www.orpdmp.com/orpdmpfiles/PDF_Files/Reports/Statewide_10.01.11_to_03.31.12.pdf .
9 -Swedlow A, Ireland J, Johnson G. Prescribing patterns of schedule II opioids in California Workers’ Compensation. Cal. Workers’ Compensation Update. 2011 Mar:1–12. Available at: http://www.cwci.org/research.htmlExternal Web Site Icon. Also available at: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/ . Accessed10/22/14.
10 -Substance Abuse and Mental Health Services Administration. Connecting Prescribers and Dispensers to PDMPs through Health IT: Six Pilot Studies and Their Impact. 2012. Available at: http://www.healthit.gov/sites/default/files/pdmp_pilot_studies_summary.pdf . Accessed 10/22/14.
11 -PDMP: The Game Changer? Healthesystems. RxInformer spring 2013. Page 24. Available at: www.healthesystems.com/rxinformer . Accessed 10/22/14
12 -Department of Health & Human Services. Addressing Prescription Drug Abuse in the United States. Current Activities and Future Opportunities. September 2013. Page 27. Available at: http://www.cdc.gov/HomeandRecreationalSafety/pdf/HHS_Prescription_Drug_Abuse_Report_09.2013.pdf . Accessed 10/22/14.
13 -Edney, Anna. Marijuana Considered for Looser Restrictions by U.S. FDA. Bloomberg. Available at: http://www.bloomberg.com/news/2014-06-20/drug-regulators-study-easing-u-s-marijuana-restrictions.html . Accessed 10/22/14.
14 -Office of National Drug Control Policy, The White House. Marijuana Resource Center: State Laws Related to Marijuana. Available at: http://www.whitehouse.gov/ondcp/state-laws-related-to-marijuana . Accessed 10/22/14
15 -National Institutes of Health. NIH system to monitor emerging drug trends. July 17, 2014. Available at: http://www.nih.gov/news/health/jul2014/nida-17.htm . Accessed 10/22/14.
16 - VA/DoD Clinical Practice Guideline For Management Of Opioid Therapy For Chronic Pain. Page 37. Available at: http://www.va.gov/PAINMANAGEMENT/docs/CPG_opioidtherapy_summary.pdf . Accessed 10/16/14
17 -Centers for Disease Control and Prevention. Policy Impact: Prescription Painkiller Overdoses. Available at: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/ . Accessed 10/22/14.
18 -Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, and Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine 2011; 12: 657-667. Available at: http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html . Accessed 10/22/14
19 -Centers for Disease Control and Prevention. CDC Vitalsigns. Prescription Painkiller Overdoses in the US. November 2011. Available at: http://www.cdc.gov/vitalsigns/pdf/2011-11-vitalsigns.pdf . Accessed10/22/14.
20 -Centers for Disease Control and Prevention. National Vital Statistics System mortality data. (2012) Available at: http://www.cdc.gov/nchs/deaths.htm . Accessed10/22/14.
21 -Center for Disease Control and Prevention and Control. Prescription Painkiller Overdoses in the US. November 2011. CDC Vital Signs. Available at: http://www.cdc.gov/vitalsigns/PainkillerOverdoses/index.html . Accessed10/22/14.
22 -Centers for Disease Control and Prevention. Policy Impact: Prescription Painkiller Overdoses. Available at: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/ . Accessed 10/22/14.
23 -Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER) [online]. (2014) Available from URL: http://wonder.cdc.gov/mortsql.html .
24 - Substance Abuse and Mental Health Services Administration. Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. The DAWN Report. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; 2013. Available from URL: http://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWN-highlights.pdf
25 - Paulozzi LJ. Prescription drug overdoses: a review. Journal of Safety Research, 2012; http://www.sciencedirect.com/science/article/pii/S0022437512000540
26 -Substance Abuse and Mental Health Services Administration. Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. The DAWN Report. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; 2013. Available from http://www.samhsa.gov/data/sites/default/files/DAWN127/DAWN127/sr127-DAWN-highlights.pdf
27 -Centers for Disease Control and Prevention. Wide-ranging OnLine Data for Epidemiologic Research (WONDER) [online]. (2014) Available from URL: http://wonder.cdc.gov/mortsql.html .
28 - The Changing Face of Opioid Addiction. Medscape. Sep 08, 2014. Available at: http://www.medscape.com/viewarticle/831319 . Accessed 10/14/14
29 - The Changing Face of Opioid Addiction. Medscape. Sep 08, 2014. Available at: http://www.medscape.com/viewarticle/831319 . Accessed 10/14/14
30 -The Changing Face of Opioid Addiction. Medscape. Sep 08, 2014. Available at: http://www.medscape.com/viewarticle/831319 . Accessed 10/14/14
31 -The Changing Face of Opioid Addiction. Medscape. Sep 08, 2014. Available at: http://www.medscape.com/viewarticle/831319 . Accessed 10/14/14
Table of Contents